Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female
-
Iaisha Ali
, Tim James , Niki Meston , Fenella Wojnarowska and Brian Shine
Abstract
Background: The changes in androgen levels after the menopause and the effects of hormone replacement therapy (HRT) itself and the mode of HRT have not been established. The objectives of this study were to document the effect of age on androgen levels in a normal population of postmenopausal women and to investigate the effect of oral or transdermal HRT on androgen, oestradiol and sex hormone binding globulin (SHBG) values.
Methods: A cross-sectional study was conducted on 182 postmenopausal females aged 45–100 years, randomly recruited from the community. Serum levels of dehydroepiandrosterone sulphate (DHEAS), androstenedione, testosterone, free androgen index (FAI) and SHBG in a reference group of women, subdivided by age, menopausal status, HRT replacement and mode of HRT replacement.
Results: Age was a significant factor affecting androstenedione (<55, ≥55 years) and DHEAS (<65, ≥65 years). HRT status was found to influence values for androstenedione, SHBG and FAI. Neither HRT nor age significantly influenced testosterone.
Conclusions: The observations suggest the need to provide age-specific reference intervals for androstenedione and DHEAS but not for testosterone and SHBG. The significant effect of HRT treatment would also suggest a need for treatment associated reference intervals for androstenedione, SHBG and FAI. Suggested reference intervals for each of these partitioned groups are presented.
Clin Chem Lab Med 2009;47:202–7.
©2009 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Editorial
- 50th Anniversary of SBCC/BVKC: “International Symposium Brussels 2008: New Trends in Clinical Biology. Emerging Technologies and their Impact on Laboratory Medicine and Management”
- Reviews
- Vitamin D: current status and perspectives
- Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
- New European guidelines for cardiovascular disease prevention in clinical practice
- Review
- Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics
- Genetics and Molecular Diagnostics
- The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan
- Polymorphisms and plasma soluble levels of E-selectin in patients with chronic hepatitis B virus infection
- General Clinical Chemistry and Laboratory Medicine
- Effect of high levels of human chorionic gonadotropin and estradiol on the severity of hyperemesis gravidarum
- Freeze-thaw and matrix effects in direct high-density lipoprotein cholesterol methods
- Methodology for monitoring cytomegalovirus infection after renal transplantation
- High concentrations of haptocorrin interfere with routine measurement of cobalamins in human serum and milk. A problem and its solution
- Reference Values and Biological Variations
- Inter- and intra-individual variations of urinary endogenous metabolites in healthy male college students using 1H NMR spectroscopy
- Preanalytical errors in primary healthcare: a questionnaire study of information search procedures, test request management and test tube labelling
- Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female
- Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking
- Validation and Outcome Studies
- Comparison of calcium, magnesium, sodium, potassium, zinc, and creatinine concentration in 24-h and spot urine samples in women
- Performance of free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein-A (PAPP-A) analysis between Delfia Xpress and AutoDelfia systems in The Netherlands
- A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study
- Letters to the Editor
- Interference of IgM-λ paraprotein with biuret-type assay for total serum protein quantification
- Evaluation of BD Vacutainer® PST™II tubes for a wide range of immunoassays
- Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy
Articles in the same Issue
- Editorial
- 50th Anniversary of SBCC/BVKC: “International Symposium Brussels 2008: New Trends in Clinical Biology. Emerging Technologies and their Impact on Laboratory Medicine and Management”
- Reviews
- Vitamin D: current status and perspectives
- Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
- New European guidelines for cardiovascular disease prevention in clinical practice
- Review
- Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics
- Genetics and Molecular Diagnostics
- The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan
- Polymorphisms and plasma soluble levels of E-selectin in patients with chronic hepatitis B virus infection
- General Clinical Chemistry and Laboratory Medicine
- Effect of high levels of human chorionic gonadotropin and estradiol on the severity of hyperemesis gravidarum
- Freeze-thaw and matrix effects in direct high-density lipoprotein cholesterol methods
- Methodology for monitoring cytomegalovirus infection after renal transplantation
- High concentrations of haptocorrin interfere with routine measurement of cobalamins in human serum and milk. A problem and its solution
- Reference Values and Biological Variations
- Inter- and intra-individual variations of urinary endogenous metabolites in healthy male college students using 1H NMR spectroscopy
- Preanalytical errors in primary healthcare: a questionnaire study of information search procedures, test request management and test tube labelling
- Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female
- Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking
- Validation and Outcome Studies
- Comparison of calcium, magnesium, sodium, potassium, zinc, and creatinine concentration in 24-h and spot urine samples in women
- Performance of free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein-A (PAPP-A) analysis between Delfia Xpress and AutoDelfia systems in The Netherlands
- A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study
- Letters to the Editor
- Interference of IgM-λ paraprotein with biuret-type assay for total serum protein quantification
- Evaluation of BD Vacutainer® PST™II tubes for a wide range of immunoassays
- Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy